Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06837246 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

A NA study of Cognition and Attention, sponsored by Pharmavite.

Recruiting
Registry status
NA
Development phase
422
Enrollment target
1
Study location

NCT06837246 is a NA study of Cognition and Attention that is actively recruiting participants, run by Pharmavite. The registered enrollment target is 422 participants, above the 160-participant average among 35 other Cognition trials with a reported enrollment target (164% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06837246, a NA study of Cognition and Attention, is actively recruiting participants, sponsored by Pharmavite.

RECRUITING
Registry status
NA
Development phase
422 participants
Enrollment target
1
Study location

Study Summary

This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the United States.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Cognitive Nutritional Supplement

Study Locations (1)

Illinois

  • Biofortis Innovation Services - Addison

Trial Details

FieldValue
Enrollment Target 422 participants
Start Date 2025-02-24
Est. Completion 2025-09-30
Phase NA

Sponsor

Pharmavite

5 total trials

What the Registry Record Tells You About NCT06837246

The ClinicalTrials.gov registry entry for NCT06837246 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 160-participant average among 35 other Cognition trials with a reported enrollment target (164% higher). The listed sponsor is Pharmavite, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cognition appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06837246 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06837246 about?

NCT06837246 is a clinical study titled "A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population". This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the U...

What is the current status of trial NCT06837246?

This trial is currently recruiting. It is a NA study. The enrollment target is 422 participants. The study started on 2025-02-24. Estimated completion is 2025-09-30.

What conditions does trial NCT06837246 study?

This clinical trial studies the following conditions: Cognition, Attention, Focus, Concentration.

What interventions are being tested in trial NCT06837246?

The interventions under investigation include: Placebo (OTHER), Cognitive Nutritional Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06837246?

This trial is sponsored by Pharmavite, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06837246 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.